BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31527170)

  • 1. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.
    Qin Y; Wu CW; Taylor WR; Sawas T; Burger KN; Mahoney DW; Sun Z; Yab TC; Lidgard GP; Allawi HT; Buttar NS; Smyrk TC; Iyer PG; Katzka DA; Ahlquist DA; Kisiel JB
    Clin Cancer Res; 2019 Dec; 25(24):7396-7404. PubMed ID: 31527170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
    Kisiel JB; Dukek BA; V S R Kanipakam R; Ghoz HM; Yab TC; Berger CK; Taylor WR; Foote PH; Giama NH; Onyirioha K; Abdallah MA; Burger KN; Slettedahl SW; Mahoney DW; Smyrk TC; Lewis JT; Giakoumopoulos M; Allawi HT; Lidgard GP; Roberts LR; Ahlquist DA
    Hepatology; 2019 Mar; 69(3):1180-1192. PubMed ID: 30168613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.
    Anderson BW; Suh YS; Choi B; Lee HJ; Yab TC; Taylor WR; Dukek BA; Berger CK; Cao X; Foote PH; Devens ME; Boardman LA; Kisiel JB; Mahoney DW; Slettedahl SW; Allawi HT; Lidgard GP; Smyrk TC; Yang HK; Ahlquist DA
    Clin Cancer Res; 2018 Nov; 24(22):5724-5734. PubMed ID: 29844130
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.
    Iyer PG; Taylor WR; Johnson ML; Lansing RL; Maixner KA; Yab TC; Simonson JA; Devens ME; Slettedahl SW; Mahoney DW; Berger CK; Foote PH; Smyrk TC; Wang KK; Wolfsen HC; Ahlquist DA
    Am J Gastroenterol; 2018 Aug; 113(8):1156-1166. PubMed ID: 29891853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
    Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9.
    Majumder S; Taylor WR; Foote PH; Berger CK; Wu CW; Mahoney DW; Bamlet WR; Burger KN; Postier N; de la Fuente J; Doering KA; Lidgard GP; Allawi HT; Petersen GM; Chari ST; Ahlquist DA; Kisiel JB
    Clin Cancer Res; 2021 May; 27(9):2523-2532. PubMed ID: 33593879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence.
    Xie H; Mahoney DW; Foote PH; Burger KN; Doering KA; Taylor WR; Then SS; Cao X; McGlinch M; Berger CK; Wu TT; Hubbard JM; Allawi HT; Kaiser MW; Lidgard GP; Ahlquist DA; Kisiel JB
    Clin Cancer Res; 2021 Jan; 27(1):141-149. PubMed ID: 33028593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
    Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
    Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study.
    Qin Y; Taylor W; Bamlet WR; Ravindran A; Buglioni A; Cao X; Foote PH; Slettedahl SW; Mahoney DW; Albert PS; Kim S; Hu N; Taylor PR; Etemadi A; Sotoudeh M; Malekzadeh R; Abnet CC; Smyrk TC; Katzka D; Topazian MD; Dawsey SM; Ahlquist D; Kisiel JB; Iyer PG
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2642-2650. PubMed ID: 32948633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
    Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
    Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls.
    Majumder S; Raimondo M; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Devens ME; Mahoney DW; Smyrk TC; Pannala R; Chari ST; Vege SS; Topazian MD; Petersen BT; Levy MJ; Rajan E; Gleeson FC; Abu Dayyeh B; Nguyen CC; Faigel DO; Woodward TA; Wallace MB; Petersen G; Allawi HT; Lidgard GP; Kisiel JB; Ahlquist DA
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):676-683.e3. PubMed ID: 31323382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer detection by DNA methylation in cervical scrapings.
    Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study.
    Iyer PG; Taylor WR; Slettedahl SW; Lansing RL; Hemminger LL; Cayer FK; Mahoney DW; Giakoumopoulos M; Allawi HT; Wu TT; Wang KK; Wolfsen HC; Antpack E; Kisiel JB
    Gastrointest Endosc; 2021 Sep; 94(3):498-505. PubMed ID: 33857451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
    Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
    BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
    Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
    Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
    PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.